Literature DB >> 2367315

Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

D S Chien1, R D Schoenwald.   

Abstract

The aqueous humor concentration of phenylephrine and its corresponding mydriatic response were measured over time in New Zealand albino rabbit eyes following a 10-microliters topical instillation of a phenylephrine HCl viscous solution (10%) or a phenylephrine oxazolidine (prodrug) suspension in sesame oil (1 and 10%). The bioavailability of a 1% prodrug suspension in the rabbit eye (AUC of aqueous humor concentration vs time) was 30% lower than that of a 10% phenylephrine solution (P less than 0.1) with the exception that the peak time occurred 34 min earlier with the prodrug. A 10% prodrug suspension increased the aqueous humor bioavailability approximately eightfold but improved the mydriatic activity (AUC of mydriasis vs time) only fourfold. The pharmacokinetic parameters, apparent absorption, and elimination rate constants, of phenylephrine and the prodrug were determined from aqueous humor concentration-time and mydriasis-time profiles. The study showed that the kinetic parameters of phenylephrine estimated from its mydriasis profile do not accurately reflect the kinetics of drug distribution in the iris. These parameters also varied with the instillation of phenylephrine solution or prodrug suspensions. A mydriatic tolerance of the pupil response was apparent after the topical instillation of phenylephrine solution. The mydriatic tolerance may be due to the decrease in receptor number in the iris dilator muscle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367315     DOI: 10.1023/a:1015808514727

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Pharmacodynamic model of tolerance: application to nicotine.

Authors:  H C Porchet; N L Benowitz; L B Sheiner
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

2.  Kinetics of drug effect by distributed lags analysis: an application to cocaine.

Authors:  R Zahler; P Wachtel; P Jatlow; R Byck
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

3.  Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.

Authors:  K J Himmelstein; I Guvenir; T F Patton
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

4.  Plasma levels and effects of metoprolol after single and multiple oral doses.

Authors:  P Collste; K Haglund; C von Bahr
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

Review 5.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

6.  Pharmacokinetics of topical phenylephrine hydrochloride in the normal human eye.

Authors:  S Matsumoto; T Tsuru; M Araie; Y Komuro
Journal:  Jpn J Ophthalmol       Date:  1982       Impact factor: 2.447

7.  Mydriatic effect of four drugs determined with pupillograph.

Authors:  H D Gambill; K N Ogle; T P Kearns
Journal:  Arch Ophthalmol       Date:  1967-06

8.  Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.

Authors:  V H Lee; J R Robinson
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

9.  A model eliciting transient responses.

Authors:  E B Ekblad; V Licko
Journal:  Am J Physiol       Date:  1984-01

10.  Kinetics of cocaine distribution, elimination, and chronotropic effects.

Authors:  M J Chow; J J Ambre; T I Ruo; A J Atkinson; D J Bowsher; M W Fischman
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

View more
  3 in total

Review 1.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

2.  Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.

Authors:  Y Qiu; J K Guillory; R D Schoenwald
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

3.  Physicochemical characterization of high- and low-melting phenylephrine oxazolidines.

Authors:  Y Qiu; R D Schoenwald; J K Guillory
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.